Literature DB >> 7803283

Platelet procoagulant complex assembly in a tissue factor-initiated system.

D M Monroe1, H R Roberts, M Hoffman.   

Abstract

The aim of this study was to examine the assembly of the factor IXa/VIIIa (Xase) and factor Xa/Va (IIase) complexes on the platelet surface in a system designed to mimic tissue factor-initiated coagulation. The experimental system contained tissue factor-bearing monocytes, unactivated platelets, and plasma concentrations of factors V, VIII, IX, X, prothrombin, tissue factor pathway inhibitor (TFPI), antithrombin III (ATIII), and small amounts of factor VIIa. The time courses of platelet activation, coagulation factor binding and thrombin generation were compared. In this system, thrombin generation by the combination of monocytes and platelets was synergistic compared to each cell type alone. Platelet activation and thrombin generation were minimal in the absence of prothrombin or factor X. After a lag period, platelet activation began, followed by progressive binding of factors Va and VIIIa. This was followed by factor IXa and Xa binding and the onset of thrombin generation. Unexpectedly, a transient early increase in platelet-associated factor IX and X was also seen, that was due to release from platelets. The amount of factor IX bound to isolated activated platelets was increased by addition of factor VIIIa, or by activation of factor IX to IXa. In contrast, factor VIIIa binding was not altered by the presence of factor IX or IXa. We conclude that in a tissue factor-initiated system, assembly of the procoagulant complexes on the platelet surface begins after platelet activation occurs. Platelet activation requires thrombin generation in the vicinity of the tissue factor bearing cells. The cofactors Va and VIIIa bind to the platelets and facilitate subsequent binding of factors IXa and Xa to form functional procoagulant complexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803283     DOI: 10.1111/j.1365-2141.1994.tb05032.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis?

Authors:  M Hoffman; D M Monroe; R A Roubey
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.

Authors:  E Persson; M Kjalke; O H Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Cellular regulation of blood coagulation: a model for venous stasis.

Authors:  James E Campbell; Kathleen E Brummel-Ziedins; Saulius Butenas; Kenneth G Mann
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

Review 4.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

5.  Investigation of a common canine factor VII deficiency variant in dogs with unexplained bleeding on autopsy.

Authors:  Jessica A Clark; Stephen B Hooser; Dayna L Dreger; Grant N Burcham; Kari J Ekenstedt
Journal:  J Vet Diagn Invest       Date:  2022-08-10       Impact factor: 1.569

Review 6.  Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.

Authors:  Ulla Hedner; Nikolai C Brun
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

Review 7.  Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.

Authors:  Pär I Johansson; Sisse R Ostrowski
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

Review 8.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

Review 9.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

10.  Varying effects of tyrosine kinase inhibitors on platelet function-A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications?

Authors:  Suryyani Deb; Niklas Boknäs; Clara Sjöström; Anjana Tharmakulanathan; Kourosh Lotfi; Sofia Ramström
Journal:  Cancer Med       Date:  2019-11-12       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.